SlideShare a Scribd company logo
Peritoneal Dialysis Conference
Maj. Chaken Maniyan M.D.
Division of Nephrology, Department of Medicine
Phramongkutklao Hospital
23.5.2017
Demographic data
§ผู้ป่วยหญิงไทยคู่ อายุ 74 ปี
§ภูมิลำเนา : เขตลาดพร้าว กทม.
§ศาสนาพุทธ
§สิทธิการรักษา : ประกันสุขภาพทั่วหน้า รพ.รร. 6
Case Presentation
§ESRD initiated CAPD since March 2016 (TK insertion since Feb 2016)
§ Initial PD prescription: 1.5 % PD fluid 2 L x 4 cycle/d
dwell time 4 hr/cycle
§ Average UF 200-400 ml/d
§ Residual urine 600-700 ml/d
§Hypertension
§Dyslipidemia
§Gout
§Primary hyperthyroidism
§Vitamin D deficiency
Chief complaint
§ เหนื่อยมากขึ้น 2 สัปดาห์ ก่อนมาโรงพยาบาล (ก.พ.2560)
Present illness
§ 2 สัปดาห์ : มีอาการเหนื่อยมากขึ้น FC IIà III
§อาการเป็นตอนท่านอนมากกว่าท่านั่ง ไม่มีแน่นหน้าอก ไม่มีลุกขึ้นมาเหนื่อยตอนกลางคืน
§อาการเป็นมากขึ้นในช่วงที่ใช้น้ำยาล้างหน้าท้อง ไม่มีอาการปวดท้อง ไม่มีน้ำยาขุ่น ไม่มีไข้ ไม่มีถ่ายเหลว
§อาการเหนื่อย ตะแคงขวาแล้วดีขึ้น
§ไม่มีอาการขาบวม ไม่มีหน้าบวม
§Net UF from PD +100-300 ml (ขาดทุน) , residual urine 400-500 ml/d(เท่าเดิม)
§ดื่มน้ำวันละ 1-1.5 ลิตร
§ไม่มีเบื่ออาหารหรือคันตามตัว ไม่มี ตะคริว
§2 วัน อาการเหนื่อยเป็นมากขึ้น ญาติจึงพามารพ.
Personal history
§Personal history
§ ปฏิเสธยาลูกกลอน/ยาสมุนไพร/ยาต้ม/ยาชุด
§ ปฏิเสธดื่มสุรา สูบบุหรี่
§ ไม่มีสัตว์เลี้ยงที่บ้าน
§ Family history :
§ ปฏิเสธโรคไตในครอบครัว
Current medication
§ Losartan(50) 1x2 o pc
§ Hydralazine (25) 2x4 o pc
§ Metroprolol (100) ½ x1 o pc
§ Furosemide (500) 1x1 o pc เช ้า
§ Aldactone (25) 2x1 o pc
§ Amlodipine(10) 1x1 o pc
§ Ferrous fumarate (200) 1x3 o ac
§ Simvastatin (10) 1 x1 o hs
§ PTU (50) 1x1 o pc
§ CaCO3(1) 1x2 with meal
§ Vitamin D2 (20,000) 1cap o จันทร์ พฤหัส
§ KCl elixir 15 ml o OD
§ Pregabalin (25) 1x1 o hs
Physical examination
§ V/S: BT 36.6 C, RR 22 /min, BP 151/61 mmHg, HR 110 /min BW 66 kg
§GA:An elderly Thai female, alert , follow to command
§HEENT: mildly pale conjunctivae, anicteric sclera, no thyroid gland enlargement
§LN: not palpable
§CVS: JVP 4 cm above sternal angle , normal S1 S2, no murmur
§Lungs: Trachea in midline , Normal chest contour , dullness on percussion over
left lung , decreased breath sound left lower lung, no wheezing
§Abdomen: mild distension, active bowel sound, soft, not tender, no guarding,TK
insertion no erythema, no purulent discharge, not tender along tunnel route
§Extremities : No pitting edema
§ Neuro : good consciousness , follow to command, no facial palsy
§ No weakness , decrease pinprick sensation both lower legs , BBK plantar
flexion
Problem lists
§Progressive dyspnea in ESRD on CAPD patient
§Possible Left pleural effusion
§Hypertension
§Dyslipidemia
§Gout
§Primary hyperthyroidism
§Vitamin D deficiency
What is provision diagnosis
and differential diagnoses ?
Laboratory investigation
Lab Result
CBC Hb 10.9 g/dL, Hct 37.9 % MCV 84 fl. RDW 17 %, WBC 8,100, N 73.8%, L 12% M 14% E 0.1% B
0.2% Platelet 267,000
Blood chemistry BUN 69 Cr 12.9 mg/dL Na 138 K3.29 Cl 93.1 HCO3 20.3 mEq/L Ca 8.6 , P 2.3 mg/dL
Lactate 7.3 mg/dL
ABG pH 7.44, pCO2 24.4, pO2 113.2, HCO3 20
LFT TP 4 Alb 2.8 AST 32 ALT 35 ALP 88
CXR
Date Fluid. Color WBC PMN Mono RBC Protein Albumin LDH Lactate Sugar ADA
20/2 Pleural Turbid 230 12 88 205 1.7 1 65 12 143 13
Pertoneal Clear 2 - - - 1.6 1 - 74 139 -
Pleural and peritoneal
fluid analysis
Serum protein = 4 g/dL. Pleural/serum ratio = 0.4
Serum albumin 2.9 g/dL
Serum LDH = 192 U/L Pleural/serum ratio = 0.33
Serum glucose = 109
Film KUB
What is the further investigation
and RRT management in this case
Initial management
§ 1.5 % PDF 1500 ml, dwell time 3 hour for 3 cycle
§ 4.25 % PDF 1500 ml, dwell time 4 hour last cycle
§ Dry abdomen in nighttime
§ Increase furosemide to 1 gm /d
§ Advice patient to dialysis in upright position
Nuclear Scintigraphy
Follow up March 2017
§ April 2017:
§ มา F/U หลังจาก ปรับ PD prescription อาการหอบ
เหนื7อยลดลง ไม่ปวดท ้อง ไม่มีไข ้ถ่ายอุจจาระ ทุกวัน
ไม่มีท ้องผูก
§NET UF from PD = 200 ml/d
§Residual urine = 500-600 ml/d
Film KUB
Follow up April 2017
§ มา F/U มีปัญหา PD ขาดทุนตลอด วันละ 1500-2000 ml
ตลอด ปัสสาวะออกวันละ 500-600 ml ต่อวัน
§มีอาการบวม หอบเหนื7อยมากขึGน +orthopnea , + PND
§ไม่มีไข ้ไม่มีท ้องผูก ถ่ายอุจจาระได ้ทุกวัน
Physical examination
§ V/S: BT 36.6 C, RR 22 /min, BP 190/100 mmHg, HR 92 /min BW 69 kg
§GA:An elderly Thai woman, follow to command
§HEENT: mildly pale conjunctivae, anicteric sclera, no thyroid gland enlargement
§LN: not palpable
§CVS: JVP 4 cm above sternal angle , normal S1 S2, no murmur
§Lungs: Trachea in midline , Normal chest contour , equal breath sound
§Abdomen: mild distension, active bowel sound, soft, not tender, no guarding,TK
insertion no erythema, no purulent discharge, not tender along tunnel route
§Extremities : pitting edema 2+
§ Neuro : good consciousness , follow to command, no facial palsy
§ No weakness , decrease pinprick sensation both lower legs , BBK plantar
flexion
CXR PA Upright
Plain film KUB (repeat)
Laboratory investigation
Lab Result
CBC Hb 9.4 g/dL, Hct 27.9 % MCV 84 fl. RDW 17 %, WBC 10,100, N 73.8%, L 12% M 14% E 0.1% B
0.2% Platelet 287,000
Blood chemistry BUN 99 Cr 12.9 mg/dL Na 138 K5.29 Cl 93.1 HCO3 16.3 mEq/L Ca 8.6 , P 3.4 mg/dL
ABG pH 7.44, pCO2 24.4, pO2 113.2, HCO3 20
Management
§ Consult surgery forTK catheter revision
§ Temporary acute hemodialysis
Peritoneal Dialysis : Catheter Placement
and Complication Management
Requirement of catheter for dialysis adequacy
§Peritoneal membrane w/o sclerosis/adhesions
§Abdominal wall w/o leaks or hernias
§Subcutaneous tract w/o infection
§Skin exit site w/o infection
§Catheter surface w/o persistent biofilm
5th edition Handbook of Dialysis
Why Is Design or Surgical Technique Important?
§ Reduce risk for catheter-related complications
Mechanical Complications
Inadequate Hydraulic Function
Omental Entrapment
Leaks
Infectious Complications
Exit-Site
Tunnel
Peritonitis
5th edition Handbook of Dialysis
Catheter Material
§ Catheters are made either of polyurethane or silicone
§ Either mupirocin or gentamicin - damage polyurethane
§ Manifestations of Damage:
§Opacification of catheter
§Leaks – leading to peritonitis
§Rarely – rupture of catheter
5th edition Handbook of Dialysis
Common used catheter set:
Double cuff, swan neck, coiled Tenckhoff design.
avoid cuff extrusions.
5-mm external diameter and
internal diameters of 2.6 -3.5 mm.
Decreases pain during PD and less likely to migrate.
Nebel M, et al .Adv Perit Dial 7:208–213, 1991
Prevent infection (ESI,Tunnel infection, peritonitis)
Internal diameters for PD catheters
(outer diameter of 5 mm )
Flex-Neck	Tenckhoff catheter	(silicone)
Internal diameter 3.5 mm
Cruz Tenckhoff catheter (polyurethane)
Internal diameter 3.1 mm
standard Tenckhoff (silicone)
Internal diameter 2.6 mm
T-fluted catheter (Ash Advantage, silicone)
Adapted from Crabtree J. Kidney Int Suppl 2006; 70: S27-37
Proper position of peritoneal cuffs
External Segment
Tunneled Segment
Intra-Peritoneal Segment
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
Intraperitoneal portion
1. Straight Tenckhoff, 8-cm ,1-mm side holes
2. CurledTenckhoff, 16-cm, 1-mm side holes
3. Straight Tenckhoff/ perpendicular silicone
discs (Toronto-Western)
4. T-fluted catheter (Ash Advantage), aT-
shaped catheter with grooved limbs
positioned against the parietal peritoneum
1 2
3
4
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
Superiority of intraperitoneal catheter design
§No consistent data to support
§2014 meta-analysis : straight segments compare with
coiled
§remain functional at 2 years (79 /55 %)
§faster failure (1.4/2.1 yrs) (inadequate small-solute
clearance
§lower rate of late catheter tip migration (5VS 32 %)
Hagen SM, et al . Kidney Int 2014; 85:920.
Johnson et al,Am J Kidney Dis, 2006
Subcutaneous portion
§1-2 extraperitoneal Dacron
(made from polyester)
§Induce fibrous plug
§fix catheter in position
§prevent fluid leaks
§prevent bacterial migration
§Similar rates of ESI, peritonitis,
migration, leakage, removal, and
dysfunction
Extraperitoneal portion
Selection of swanneck or straight catheters
determined by:
-Belt line
-Placement of exit site
Insertion techniques
§ Percutaneous approach
§ Peritoneoscopic approach
§ Open surgical approach
§ Laparoscopic approach
§ Advanced laparoscopic (rectus sheath tunneling, selective
prophylactic omentopexy and adhesiolysis)
Choice of operator/technique depend on local expertise
Joni H.Hansson et al,AJKD Update on Peritoneal Dialysis:Core Curriculum 2016
Advanced laparoscopic :
Rectus Sheath Tunneling
Advanced laparoscopic : Omentopexy
Guest S. Handbook of Peritoneal Dialysis, 2011
Probability of Free of Mechanical Flow Obstruction
At 24 Months Increased by Newer Techniques
Crabtree JH et al .Am Surg . 2005 ; 71:135-143
Proper position of Catheter
§Intraperitoneal portion - between visceral and parietal
peritoneum, near pouch of Douglas (cal de sac)
§ Hydraulic function of catheter AND
§ Minimize omental entrapment
§Inner cuff should be inserted in rectus muscle to prevent
leaks.
§Outer cuff - subcutaneous tissue (create a dead space in
between cuffs) approximate 2 cm
§Subcutaneous tract and exit site should face downward and
laterally to avoid exit site infection.
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
Location of deep cuff
Placingde ep cuff in abdominal musculature
- promotes tissue ingrowth
- minimizes pericatheter hernias, leaks
- catheter extrusion, and exit site erosion
Principle of exit site placement
§Away from belt-lines, skin creases, and folds
§Clearly visible to daily exit site care
§About one inch from the superficial cuff
Selection of various catheter
Belt line below umbilicus à swan-neck catheter preferred
if lateral point , a straight catheter is preferable
Selected patients prefer uppper or presternal tips
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
Presternal Exit-Site is Easily Visualized and
Remote from Urostomy
Guest S. Handbook of Peritoneal Dialysis, 2011
Indication for presternal catheter
§ Morbid obesity
§ Floppy abdominal skin folds
§ Presence of stoma(colostomy, ileostomy, or urostomy)
§ Incontinence of urine or feces
§Very young children who wear diapers
§ Patients with Hx of recurrent catheter infections
Guest S. Handbook of Peritoneal Dialysis, 2011
Postoperative catheter care
§Covered with a nonocclusive dressing and should not be
used for 10-14 days.
§Catheter should be flushed at least 1-2 times /wk with
saline or dialysate solution
§Low-volume PD may be attempted within 24 hours in case
of emergency
Song JH, Kim GA, Lee SW, et al:. Perit Dial Int 2:194–199, 2000
ISPD : Implantation protocol
§Preoperative:
§ Check for hernias/ MRSA and nasal carriage of S. aureus;
§ Suitable catheter length
§ Marking exit site with the patient sitting or standing. •
§ Preparing bowel with laxatives; ensuring bladder emptying;
administering prophylactic antibiotics
§ Post-procedure: flushing catheter and cap off using suitable dialysate
§ Covering exit site w/ dressing and, if possible, not disturbing for 5 –
10 days;
§ Immobilizing the catheter
§ Choice of antibiotic should be based upon local guidelines, with
consideration given to efficacy, risks of selection of resistant
organisms, and development of Clostridium difficile colitis
ISPD CLINICAL PRACTICE GUIDELINES FOR PERITONEAL ACCESS , Peritoneal Dialysis International,Vol. 30, pp. 424–429, 2010
Audit standards for catheter-related complications:
§Bowel perforation: < 1%
§Significant hemorrhage: < 1%
§Exit-site infection in 2 weeks of insertion: < 5%
§Peritonitis within 2 weeks of insertion: < 5%
§Functional catheter problem requiring manipulation or
replacement or leading to technique failure: < 20%
§At least every 12 months, a combined meeting between
surgeons (or other healthcare providers inserting PD
catheters) and the nephrology team should be held to
review PD catheter data
ISPD CLINICAL PRACTICE GUIDELINES FOR PERITONEAL ACCESS , Peritoneal Dialysis International,Vol. 30, pp. 424–429, 2010
Complication of chronic catheter
§Peri-catheter leak
§Infusion pain
§Drain pain
§Outflow failure
§Cuff extrusion
§Pleural effusion
§EPS
§Infection
Early pericatheter leak
§3 factors :
§ catheter implantation technique
§ timing of initiation
§ strength of abdominal wall tissues.
§Confirmed by glucose dipstick indicating high glucose
§Discontinue for 1–3 weeks usually spontaneous cessation
§Leakage through exit site tunnel :: ↑ risk infection
Late pericatheter leaks
§Caused by pericannular hernia or occult tunnel
infections, (with separation of the cuffs)
§If abdominal wall is weak : track may dilate , develop true
hernia.
§Most late leaks and pericatheter hernias are best managed
by catheter replacement.
Pericatheter leakage
§Treatment
§Reduce physical activity
§Reduce dialysate volumes
§Conversion to cycler
§Temporary conversion to HD
§If conservative measures fails then surgical repair of deep
cuff or catheter replacement
Infusion pain
§ Usually resolved in several weeks in new patients
§ Persistent pain
§ Acidity (pH 5.2–5.5) of conventional lactate based dialysate
§ Use of bicarbonate/lactate- buffered dialysate (pH 7.0–7.4)
§ 1% or 2% lidocaine solution added to the dialysate (5 mL/L)
§Other causes
§ hypertonic dialysate
§ aged dialysate
§ overdistended abdomen
§ extreme temperature
§ straight-tip cathters (jet effect).
§ catheter malposition with tip against abdominal wall
Drain pain
§Common in early days after initiation of dialysis.
§Tip of catheter against sensitive parietal peritoneum
§ Constipation (bowel around catheter in pelvis)
§ More frequently in APD due to hydraulic suction
§ If persistent pain à avoid complete drainage of effluent
Outflow failure
§Definition: Incomplete recovery of instilled
dialysate
§Incidence: 5-20%
§Etiologies
§Constipation (anytime)
§Catheter malposition (days)
§Intraluminal catheter occlusion by thrombus
§Extraluminal catheter occlusion by omentum or
adhesions (weeks)
§Kinking (soon after placement, positional)
§Loss of dialysate from peritoneal cavity
Diagnosis
§History
§ Flow disturbance – inflow, outflow or both
§ When was the catheter placed
§ Constipation
§ Pain
§ Dyspnea
§ Fibrin in dialysate drain
§Plain film
§ Severe constipation
§ Catheter malposition
§Lost dialysate: pericatheter dialysate leakage; either internal
or external
Treatment
§Constipation
§More than half of the cases are cured with releif of
constipation
§Laxatives, stool softeners, suppositories or enema
§Fibrin clot
§Heparin 500-1000 units/L of dialysate for lysis
§Urokinase – instilled in catheter for 1 hour and then
removed
§Recombinant tPA – used if obstruction is refractory
Treatment
§Malpositioned catheter
§Fluoroscopy with stiff wire manipulation
§Redirection either laproscopically or surgically
§Replace catheter if not successful
§Catheter kinking
§Usually requires catheter replacement
§Abdominal exploration may be necessary for catheter
redirection, omentectomy or adhesiolysis or catheter
replacement
Catheter cuff extrusion
§Catheter cuff erodes through the skin to the outer
abdominal wall
§Can be 2nd from ESI or superficial cuff placement
§Incidence: 3.5 – 7%; no specific association with
catheter type and method of placement
§Treatment: depends on presence or absence of
infection
§ No infection: extruding cuff removed by opening the
subcutaneous tissue at exit site and trimming the cuff under
sterile conditions
§ Infection present: remove the catheter
Pleural effusion associated peritoneal dialysis
§Possible etiologies:
§Volume overload, CHF
§Local pleural process
§Peritoneal dialysate (pleuroperitoneal fistula)
§Suspicion of peritoneal dialysate in a non-edematous pt
with inadequate UF
§Incidence: 1.6%, more common in females
§ADPKD patients prone to have due to decreased
abdominal capacity
5th edition	Handbook	of	Dialysis
Pleural effusion
§Usually occurs early after starting PD
§Unrelated to dialysate volumes
§Hypotheses:
§Congenital communication between pleura and
peritoneum. Dissection of fluid through defects around
major vessels and the esophagus
§Combination of increased intra-abdominal pressure and
negative intra-thoracic pressure may open small defects in
the diaphragm
5th edition	Handbook	of	Dialysis
Pleural effusion
§Clinical features
§Can be asymptomatic
§Dyspnea on exertion
§Inadequate UF
§More common on right side
§Occurs early after PD initiation, 50% of cases within 1st
month
§Diagnosis: glucose level higher than serum (no cut point)
§ Nuclear scintigraphy is the most reliable test
5th edition	Handbook	of	Dialysis
Pleural effusion
§Treatment: depends on acuity and severity
§Thoracentesis
§Drain peritoneal cavity and avoid overnight supine dwells
§If recurrent and unresponsive: chemical pleurodesis using
talc, tetracycline
§Surgical correction if diaphragmatic defect is identified
§Temporary conversion to HD
5th edition	Handbook	of	Dialysis
Pleuro-peritoneal fistula
Hemoperitoneum
§ Benign causes
§Menstruation/Ovulation
§Trauma
§Coagulopathy
§Ruptured renal/ ovarian cyst
§Serious causes
§Ischemic bowel
§Colon cancer
§Pancreatitis
§Encapsulating peritoneal sclerosis
§Urologic malignancy
§Treatment
§IP heparin to avoid clotting of catheter
§Flushes
§Investigations depend on suspected cause
5th edition	Handbook	of	Dialysis
Encapsulating peritoneal sclerosis
§Rare: Incidence: 0.5 – 2.8%
§ Stage 1- Pre-EPS stage:
§ Asymptomatic with mild ascites and no inflammation
§ Stage 2- Inflammatory stage:
§ nausea and diarrhea (partial encapsulation of bowel and intestinal swelling)
§ mild inflammation with fibrin exudation is present.
§ Stage 3- Encapsulation:
§ Symptoms of bowel obstruction due to formation of fibrous cocoon
causing encapsulation.
§ Stage 4- Chronic stage of ileus:
§ Absolute bowel obstruction caused by thickening of encapsulating fibrous
cocoon
§Mortality: 30–63%
§Both incidence and mortality increase with increased time on PD
Nakamoto H	Perit Dial	Int.	2005	Apr;	25	Suppl 4():S30-8.
Pathogenesis of EPS:
“Two-hit” theory
AugustineT, Nephron Clin Pract. 2009; 111(2):c149-54; discussion c154.
EPS: Diagnosis
§Markers of inflammation
§Elevated CRP
§Anemia, resistant to ESA’s
§Hypoalbuminemia
§Radiology: CT scan
§Peritoneal thickening
§Peritoneal calcification
§Tethering and cocooning of bowel
§Small or large bowel obstruction
Nephrol DialTransplant (2006) 21 [Suppl 2]: ii38–ii41
Gross pathology of EPS
CT Findings of EPS
Cameron et al:American Roentgen Ray Society Annual Meeting, 2010
CT Findings of EPS
Cameron et al:American Roentgen Ray Society Annual Meeting, 2010
EPS: Treatment
§Corticosteroids:
§ Useful in inflammatory phase
§ Both pulse steroids or daily therapy can be used
§ Reported 38.5% remission rate with corticosteroids
§Tamoxifen: case reports
§Surgical treatment
§ Surgical lysis of intestinal adhesions and stripping of fibrous cocoon
§ Indications for surgery:
§ recurrent bowel obstruction
§ worsening nutritional status
§ failure medication
Mario	R.	,	et	al	Nature	Reviews	Nephrology 7, 528-538 (September	2011)
Absolute contraindication for PD
ที่มา :คู่มือบริหารกองทุนหลักประกันสุขภาพแห่งชาติ ปี
งบประมาณ 2560
สิทธิการรักษา
สิทธิการรักษา
สิทธิการรักษา
Thank you for your attention

More Related Content

What's hot

Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
Chioma Iheme
 
Post obstructive diuresis
Post obstructive diuresisPost obstructive diuresis
Post obstructive diuresis
Garima Aggarwal
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
MNDU net
 
Brief pathway to handle temporary HD catheter
Brief pathway to handle temporary HD catheterBrief pathway to handle temporary HD catheter
Brief pathway to handle temporary HD catheter
MNDU net
 
Anticoagulation in hemodialysis
Anticoagulation in hemodialysisAnticoagulation in hemodialysis
Anticoagulation in hemodialysis
Vishal Ramteke
 
Kamc crrt training
Kamc crrt trainingKamc crrt training
Kamc crrt training
mohamed hassan abbass
 
Vascular access
Vascular accessVascular access
Vascular access
Abdulsalam Taha
 
Physiological Principles of Hemodialysis - Solve the Crosswords
Physiological Principles of Hemodialysis - Solve the CrosswordsPhysiological Principles of Hemodialysis - Solve the Crosswords
Physiological Principles of Hemodialysis - Solve the Crosswords
MNDU net
 
CRRT
CRRTCRRT
Tunneled catheter insertion
Tunneled catheter insertionTunneled catheter insertion
Tunneled catheter insertion
FarragBahbah
 
Vascular access 2019
Vascular access 2019Vascular access 2019
Vascular access 2019
FarragBahbah
 
Dialysis in pregnancy
Dialysis in pregnancy Dialysis in pregnancy
Dialysis in pregnancy
hayam mansour
 
Adequacy of haemodialysis
Adequacy of haemodialysisAdequacy of haemodialysis
Adequacy of haemodialysis
Dr Narinder Sharma
 
Hemodialysis vascular catheters review
Hemodialysis vascular catheters review Hemodialysis vascular catheters review
Hemodialysis vascular catheters review
JAFAR ALSAID
 
Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy
Muhammad Asim Rana
 
Dialysis prescription
Dialysis prescriptionDialysis prescription
Dialysis prescription
Dr. Prem Mohan Jha
 
Hemodialysis Adequacy
Hemodialysis AdequacyHemodialysis Adequacy
Hemodialysis Adequacy
EllyanaFarina1
 
renal replacement therapies
renal replacement therapiesrenal replacement therapies
renal replacement therapies
Ria Saira
 
Complications of peritoneal dialysis
Complications of peritoneal dialysisComplications of peritoneal dialysis
Complications of peritoneal dialysis
Hofstra Northwell School of Medicine
 
Principles of hemodialysis
Principles of hemodialysisPrinciples of hemodialysis
Principles of hemodialysis
saihari17
 

What's hot (20)

Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
 
Post obstructive diuresis
Post obstructive diuresisPost obstructive diuresis
Post obstructive diuresis
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
 
Brief pathway to handle temporary HD catheter
Brief pathway to handle temporary HD catheterBrief pathway to handle temporary HD catheter
Brief pathway to handle temporary HD catheter
 
Anticoagulation in hemodialysis
Anticoagulation in hemodialysisAnticoagulation in hemodialysis
Anticoagulation in hemodialysis
 
Kamc crrt training
Kamc crrt trainingKamc crrt training
Kamc crrt training
 
Vascular access
Vascular accessVascular access
Vascular access
 
Physiological Principles of Hemodialysis - Solve the Crosswords
Physiological Principles of Hemodialysis - Solve the CrosswordsPhysiological Principles of Hemodialysis - Solve the Crosswords
Physiological Principles of Hemodialysis - Solve the Crosswords
 
CRRT
CRRTCRRT
CRRT
 
Tunneled catheter insertion
Tunneled catheter insertionTunneled catheter insertion
Tunneled catheter insertion
 
Vascular access 2019
Vascular access 2019Vascular access 2019
Vascular access 2019
 
Dialysis in pregnancy
Dialysis in pregnancy Dialysis in pregnancy
Dialysis in pregnancy
 
Adequacy of haemodialysis
Adequacy of haemodialysisAdequacy of haemodialysis
Adequacy of haemodialysis
 
Hemodialysis vascular catheters review
Hemodialysis vascular catheters review Hemodialysis vascular catheters review
Hemodialysis vascular catheters review
 
Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy
 
Dialysis prescription
Dialysis prescriptionDialysis prescription
Dialysis prescription
 
Hemodialysis Adequacy
Hemodialysis AdequacyHemodialysis Adequacy
Hemodialysis Adequacy
 
renal replacement therapies
renal replacement therapiesrenal replacement therapies
renal replacement therapies
 
Complications of peritoneal dialysis
Complications of peritoneal dialysisComplications of peritoneal dialysis
Complications of peritoneal dialysis
 
Principles of hemodialysis
Principles of hemodialysisPrinciples of hemodialysis
Principles of hemodialysis
 

Similar to Peritoneal Dialysis catheter complication CAPD Chaken 2017

PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfPD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
Ayman Seddik
 
Chronic renal failure, surgical management
Chronic renal failure, surgical managementChronic renal failure, surgical management
Chronic renal failure, surgical management
Mokgwane Eutlwetse Sparks
 
Ckd&obstr uropathypnan,ifejan2012
Ckd&obstr uropathypnan,ifejan2012Ckd&obstr uropathypnan,ifejan2012
Ckd&obstr uropathypnan,ifejan2012
drzin
 
UTI in kidney transplantation recipients 2017
UTI in kidney transplantation recipients 2017UTI in kidney transplantation recipients 2017
UTI in kidney transplantation recipients 2017
CHAKEN MANIYAN
 
Hypospadias ppt.
Hypospadias ppt.Hypospadias ppt.
Hypospadias ppt.
Omer Ahmad
 
Urethral Catheterization
Urethral CatheterizationUrethral Catheterization
Urethral Catheterization
Eko indra
 
Pae 5
Pae 5Pae 5
Pae 5
pryce27
 
Overview of peritoneal dialysis
Overview of peritoneal dialysisOverview of peritoneal dialysis
Overview of peritoneal dialysis
ปิติ นิยมศิริวนิช
 
Why Wound Gape ? - Optimising Post Surgical Wound Healing
Why Wound Gape ? - Optimising Post Surgical Wound HealingWhy Wound Gape ? - Optimising Post Surgical Wound Healing
Why Wound Gape ? - Optimising Post Surgical Wound Healing
Niranjan Chavan
 
Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017
CHAKEN MANIYAN
 
upper gi hemorrhage(2).pptx
upper gi hemorrhage(2).pptxupper gi hemorrhage(2).pptx
upper gi hemorrhage(2).pptx
Pradeep Pande
 
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptx
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptxANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptx
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptx
DrVANDANA17
 
Case Capsule
Case CapsuleCase Capsule
Case Capsule
rrsolution
 
Tapping methodology in modern and ayurvedic therapy
Tapping methodology in modern and ayurvedic therapy Tapping methodology in modern and ayurvedic therapy
Tapping methodology in modern and ayurvedic therapy
arunithar
 
Turp CASE FINAL.pdf
Turp CASE FINAL.pdfTurp CASE FINAL.pdf
Turp CASE FINAL.pdf
BansariShah44
 
Pediatric instruments.pptx
Pediatric instruments.pptxPediatric instruments.pptx
Pediatric instruments.pptx
ssusere8f40d
 
PSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYSTPSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYST
Dr. Shouptik Basu
 
Deep Vein Pathophysiology: Reflux & Obstruction
Deep Vein Pathophysiology: Reflux & ObstructionDeep Vein Pathophysiology: Reflux & Obstruction
Deep Vein Pathophysiology: Reflux & Obstruction
Vein Global
 
Mahsa - presentation on Sepsis 8-4-22.pptx
Mahsa - presentation on Sepsis 8-4-22.pptxMahsa - presentation on Sepsis 8-4-22.pptx
Mahsa - presentation on Sepsis 8-4-22.pptx
Bishan Rajapakse
 
Fistula recto vaginal infection perspective
Fistula recto vaginal   infection perspectiveFistula recto vaginal   infection perspective
Fistula recto vaginal infection perspective
Soroy Lardo
 

Similar to Peritoneal Dialysis catheter complication CAPD Chaken 2017 (20)

PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfPD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
 
Chronic renal failure, surgical management
Chronic renal failure, surgical managementChronic renal failure, surgical management
Chronic renal failure, surgical management
 
Ckd&obstr uropathypnan,ifejan2012
Ckd&obstr uropathypnan,ifejan2012Ckd&obstr uropathypnan,ifejan2012
Ckd&obstr uropathypnan,ifejan2012
 
UTI in kidney transplantation recipients 2017
UTI in kidney transplantation recipients 2017UTI in kidney transplantation recipients 2017
UTI in kidney transplantation recipients 2017
 
Hypospadias ppt.
Hypospadias ppt.Hypospadias ppt.
Hypospadias ppt.
 
Urethral Catheterization
Urethral CatheterizationUrethral Catheterization
Urethral Catheterization
 
Pae 5
Pae 5Pae 5
Pae 5
 
Overview of peritoneal dialysis
Overview of peritoneal dialysisOverview of peritoneal dialysis
Overview of peritoneal dialysis
 
Why Wound Gape ? - Optimising Post Surgical Wound Healing
Why Wound Gape ? - Optimising Post Surgical Wound HealingWhy Wound Gape ? - Optimising Post Surgical Wound Healing
Why Wound Gape ? - Optimising Post Surgical Wound Healing
 
Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017
 
upper gi hemorrhage(2).pptx
upper gi hemorrhage(2).pptxupper gi hemorrhage(2).pptx
upper gi hemorrhage(2).pptx
 
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptx
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptxANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptx
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptx
 
Case Capsule
Case CapsuleCase Capsule
Case Capsule
 
Tapping methodology in modern and ayurvedic therapy
Tapping methodology in modern and ayurvedic therapy Tapping methodology in modern and ayurvedic therapy
Tapping methodology in modern and ayurvedic therapy
 
Turp CASE FINAL.pdf
Turp CASE FINAL.pdfTurp CASE FINAL.pdf
Turp CASE FINAL.pdf
 
Pediatric instruments.pptx
Pediatric instruments.pptxPediatric instruments.pptx
Pediatric instruments.pptx
 
PSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYSTPSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYST
 
Deep Vein Pathophysiology: Reflux & Obstruction
Deep Vein Pathophysiology: Reflux & ObstructionDeep Vein Pathophysiology: Reflux & Obstruction
Deep Vein Pathophysiology: Reflux & Obstruction
 
Mahsa - presentation on Sepsis 8-4-22.pptx
Mahsa - presentation on Sepsis 8-4-22.pptxMahsa - presentation on Sepsis 8-4-22.pptx
Mahsa - presentation on Sepsis 8-4-22.pptx
 
Fistula recto vaginal infection perspective
Fistula recto vaginal   infection perspectiveFistula recto vaginal   infection perspective
Fistula recto vaginal infection perspective
 

More from CHAKEN MANIYAN

Journal club SMART trial NEJM
Journal club  SMART trial NEJM Journal club  SMART trial NEJM
Journal club SMART trial NEJM
CHAKEN MANIYAN
 
Topic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken ManiyanTopic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken Maniyan
CHAKEN MANIYAN
 
Acute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenAcute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 Chaken
CHAKEN MANIYAN
 
Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017 Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017
CHAKEN MANIYAN
 
SPRINT substudy 2017 chaken
SPRINT substudy 2017 chakenSPRINT substudy 2017 chaken
SPRINT substudy 2017 chaken
CHAKEN MANIYAN
 
Journal club multitarget therapy lupus nephritis maintenance chaken
Journal club  multitarget therapy lupus nephritis maintenance chaken Journal club  multitarget therapy lupus nephritis maintenance chaken
Journal club multitarget therapy lupus nephritis maintenance chaken
CHAKEN MANIYAN
 
Vascular access in hemodialysis chaken 2018
Vascular access in hemodialysis chaken 2018Vascular access in hemodialysis chaken 2018
Vascular access in hemodialysis chaken 2018
CHAKEN MANIYAN
 
Membranoproliferative Glomerulonephritis MPGN chaken
Membranoproliferative Glomerulonephritis  MPGN chaken Membranoproliferative Glomerulonephritis  MPGN chaken
Membranoproliferative Glomerulonephritis MPGN chaken
CHAKEN MANIYAN
 
Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017
CHAKEN MANIYAN
 
kidney transplantation infection
kidney transplantation infectionkidney transplantation infection
kidney transplantation infection
CHAKEN MANIYAN
 
Kidney transplantation outcome complication chaken
Kidney transplantation outcome complication chakenKidney transplantation outcome complication chaken
Kidney transplantation outcome complication chaken
CHAKEN MANIYAN
 
Basic science apol1 gene and nephrocyte chaken
Basic science apol1 gene and nephrocyte chakenBasic science apol1 gene and nephrocyte chaken
Basic science apol1 gene and nephrocyte chaken
CHAKEN MANIYAN
 
Advanced in hemodialysis and biocompatbility chaken pmk
Advanced in hemodialysis and biocompatbility chaken pmkAdvanced in hemodialysis and biocompatbility chaken pmk
Advanced in hemodialysis and biocompatbility chaken pmk
CHAKEN MANIYAN
 
Heat stroke and rhabdomyolysis 2017 final
Heat stroke and rhabdomyolysis 2017 finalHeat stroke and rhabdomyolysis 2017 final
Heat stroke and rhabdomyolysis 2017 final
CHAKEN MANIYAN
 
Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017 Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017
CHAKEN MANIYAN
 
Journal club harmony trial chaken maniyan 2016
Journal club harmony trial chaken maniyan 2016Journal club harmony trial chaken maniyan 2016
Journal club harmony trial chaken maniyan 2016
CHAKEN MANIYAN
 
Kidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyanKidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyan
CHAKEN MANIYAN
 
Transplant renal artery stenosis 2016 chaken maniyan
Transplant renal artery stenosis 2016 chaken maniyanTransplant renal artery stenosis 2016 chaken maniyan
Transplant renal artery stenosis 2016 chaken maniyan
CHAKEN MANIYAN
 
Aki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanAki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyan
CHAKEN MANIYAN
 
AKI pathophysiology chaken maniyan
AKI  pathophysiology chaken maniyanAKI  pathophysiology chaken maniyan
AKI pathophysiology chaken maniyan
CHAKEN MANIYAN
 

More from CHAKEN MANIYAN (20)

Journal club SMART trial NEJM
Journal club  SMART trial NEJM Journal club  SMART trial NEJM
Journal club SMART trial NEJM
 
Topic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken ManiyanTopic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken Maniyan
 
Acute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenAcute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 Chaken
 
Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017 Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017
 
SPRINT substudy 2017 chaken
SPRINT substudy 2017 chakenSPRINT substudy 2017 chaken
SPRINT substudy 2017 chaken
 
Journal club multitarget therapy lupus nephritis maintenance chaken
Journal club  multitarget therapy lupus nephritis maintenance chaken Journal club  multitarget therapy lupus nephritis maintenance chaken
Journal club multitarget therapy lupus nephritis maintenance chaken
 
Vascular access in hemodialysis chaken 2018
Vascular access in hemodialysis chaken 2018Vascular access in hemodialysis chaken 2018
Vascular access in hemodialysis chaken 2018
 
Membranoproliferative Glomerulonephritis MPGN chaken
Membranoproliferative Glomerulonephritis  MPGN chaken Membranoproliferative Glomerulonephritis  MPGN chaken
Membranoproliferative Glomerulonephritis MPGN chaken
 
Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017
 
kidney transplantation infection
kidney transplantation infectionkidney transplantation infection
kidney transplantation infection
 
Kidney transplantation outcome complication chaken
Kidney transplantation outcome complication chakenKidney transplantation outcome complication chaken
Kidney transplantation outcome complication chaken
 
Basic science apol1 gene and nephrocyte chaken
Basic science apol1 gene and nephrocyte chakenBasic science apol1 gene and nephrocyte chaken
Basic science apol1 gene and nephrocyte chaken
 
Advanced in hemodialysis and biocompatbility chaken pmk
Advanced in hemodialysis and biocompatbility chaken pmkAdvanced in hemodialysis and biocompatbility chaken pmk
Advanced in hemodialysis and biocompatbility chaken pmk
 
Heat stroke and rhabdomyolysis 2017 final
Heat stroke and rhabdomyolysis 2017 finalHeat stroke and rhabdomyolysis 2017 final
Heat stroke and rhabdomyolysis 2017 final
 
Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017 Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017
 
Journal club harmony trial chaken maniyan 2016
Journal club harmony trial chaken maniyan 2016Journal club harmony trial chaken maniyan 2016
Journal club harmony trial chaken maniyan 2016
 
Kidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyanKidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyan
 
Transplant renal artery stenosis 2016 chaken maniyan
Transplant renal artery stenosis 2016 chaken maniyanTransplant renal artery stenosis 2016 chaken maniyan
Transplant renal artery stenosis 2016 chaken maniyan
 
Aki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanAki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyan
 
AKI pathophysiology chaken maniyan
AKI  pathophysiology chaken maniyanAKI  pathophysiology chaken maniyan
AKI pathophysiology chaken maniyan
 

Recently uploaded

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 

Peritoneal Dialysis catheter complication CAPD Chaken 2017

  • 1. Peritoneal Dialysis Conference Maj. Chaken Maniyan M.D. Division of Nephrology, Department of Medicine Phramongkutklao Hospital 23.5.2017
  • 2. Demographic data §ผู้ป่วยหญิงไทยคู่ อายุ 74 ปี §ภูมิลำเนา : เขตลาดพร้าว กทม. §ศาสนาพุทธ §สิทธิการรักษา : ประกันสุขภาพทั่วหน้า รพ.รร. 6
  • 3. Case Presentation §ESRD initiated CAPD since March 2016 (TK insertion since Feb 2016) § Initial PD prescription: 1.5 % PD fluid 2 L x 4 cycle/d dwell time 4 hr/cycle § Average UF 200-400 ml/d § Residual urine 600-700 ml/d §Hypertension §Dyslipidemia §Gout §Primary hyperthyroidism §Vitamin D deficiency
  • 4. Chief complaint § เหนื่อยมากขึ้น 2 สัปดาห์ ก่อนมาโรงพยาบาล (ก.พ.2560)
  • 5. Present illness § 2 สัปดาห์ : มีอาการเหนื่อยมากขึ้น FC IIà III §อาการเป็นตอนท่านอนมากกว่าท่านั่ง ไม่มีแน่นหน้าอก ไม่มีลุกขึ้นมาเหนื่อยตอนกลางคืน §อาการเป็นมากขึ้นในช่วงที่ใช้น้ำยาล้างหน้าท้อง ไม่มีอาการปวดท้อง ไม่มีน้ำยาขุ่น ไม่มีไข้ ไม่มีถ่ายเหลว §อาการเหนื่อย ตะแคงขวาแล้วดีขึ้น §ไม่มีอาการขาบวม ไม่มีหน้าบวม §Net UF from PD +100-300 ml (ขาดทุน) , residual urine 400-500 ml/d(เท่าเดิม) §ดื่มน้ำวันละ 1-1.5 ลิตร §ไม่มีเบื่ออาหารหรือคันตามตัว ไม่มี ตะคริว §2 วัน อาการเหนื่อยเป็นมากขึ้น ญาติจึงพามารพ.
  • 6. Personal history §Personal history § ปฏิเสธยาลูกกลอน/ยาสมุนไพร/ยาต้ม/ยาชุด § ปฏิเสธดื่มสุรา สูบบุหรี่ § ไม่มีสัตว์เลี้ยงที่บ้าน § Family history : § ปฏิเสธโรคไตในครอบครัว
  • 7. Current medication § Losartan(50) 1x2 o pc § Hydralazine (25) 2x4 o pc § Metroprolol (100) ½ x1 o pc § Furosemide (500) 1x1 o pc เช ้า § Aldactone (25) 2x1 o pc § Amlodipine(10) 1x1 o pc § Ferrous fumarate (200) 1x3 o ac § Simvastatin (10) 1 x1 o hs § PTU (50) 1x1 o pc § CaCO3(1) 1x2 with meal § Vitamin D2 (20,000) 1cap o จันทร์ พฤหัส § KCl elixir 15 ml o OD § Pregabalin (25) 1x1 o hs
  • 8. Physical examination § V/S: BT 36.6 C, RR 22 /min, BP 151/61 mmHg, HR 110 /min BW 66 kg §GA:An elderly Thai female, alert , follow to command §HEENT: mildly pale conjunctivae, anicteric sclera, no thyroid gland enlargement §LN: not palpable §CVS: JVP 4 cm above sternal angle , normal S1 S2, no murmur §Lungs: Trachea in midline , Normal chest contour , dullness on percussion over left lung , decreased breath sound left lower lung, no wheezing §Abdomen: mild distension, active bowel sound, soft, not tender, no guarding,TK insertion no erythema, no purulent discharge, not tender along tunnel route §Extremities : No pitting edema § Neuro : good consciousness , follow to command, no facial palsy § No weakness , decrease pinprick sensation both lower legs , BBK plantar flexion
  • 9. Problem lists §Progressive dyspnea in ESRD on CAPD patient §Possible Left pleural effusion §Hypertension §Dyslipidemia §Gout §Primary hyperthyroidism §Vitamin D deficiency
  • 10. What is provision diagnosis and differential diagnoses ?
  • 11. Laboratory investigation Lab Result CBC Hb 10.9 g/dL, Hct 37.9 % MCV 84 fl. RDW 17 %, WBC 8,100, N 73.8%, L 12% M 14% E 0.1% B 0.2% Platelet 267,000 Blood chemistry BUN 69 Cr 12.9 mg/dL Na 138 K3.29 Cl 93.1 HCO3 20.3 mEq/L Ca 8.6 , P 2.3 mg/dL Lactate 7.3 mg/dL ABG pH 7.44, pCO2 24.4, pO2 113.2, HCO3 20 LFT TP 4 Alb 2.8 AST 32 ALT 35 ALP 88
  • 12. CXR
  • 13. Date Fluid. Color WBC PMN Mono RBC Protein Albumin LDH Lactate Sugar ADA 20/2 Pleural Turbid 230 12 88 205 1.7 1 65 12 143 13 Pertoneal Clear 2 - - - 1.6 1 - 74 139 - Pleural and peritoneal fluid analysis Serum protein = 4 g/dL. Pleural/serum ratio = 0.4 Serum albumin 2.9 g/dL Serum LDH = 192 U/L Pleural/serum ratio = 0.33 Serum glucose = 109
  • 15. What is the further investigation and RRT management in this case
  • 16. Initial management § 1.5 % PDF 1500 ml, dwell time 3 hour for 3 cycle § 4.25 % PDF 1500 ml, dwell time 4 hour last cycle § Dry abdomen in nighttime § Increase furosemide to 1 gm /d § Advice patient to dialysis in upright position
  • 18. Follow up March 2017 § April 2017: § มา F/U หลังจาก ปรับ PD prescription อาการหอบ เหนื7อยลดลง ไม่ปวดท ้อง ไม่มีไข ้ถ่ายอุจจาระ ทุกวัน ไม่มีท ้องผูก §NET UF from PD = 200 ml/d §Residual urine = 500-600 ml/d
  • 20. Follow up April 2017 § มา F/U มีปัญหา PD ขาดทุนตลอด วันละ 1500-2000 ml ตลอด ปัสสาวะออกวันละ 500-600 ml ต่อวัน §มีอาการบวม หอบเหนื7อยมากขึGน +orthopnea , + PND §ไม่มีไข ้ไม่มีท ้องผูก ถ่ายอุจจาระได ้ทุกวัน
  • 21. Physical examination § V/S: BT 36.6 C, RR 22 /min, BP 190/100 mmHg, HR 92 /min BW 69 kg §GA:An elderly Thai woman, follow to command §HEENT: mildly pale conjunctivae, anicteric sclera, no thyroid gland enlargement §LN: not palpable §CVS: JVP 4 cm above sternal angle , normal S1 S2, no murmur §Lungs: Trachea in midline , Normal chest contour , equal breath sound §Abdomen: mild distension, active bowel sound, soft, not tender, no guarding,TK insertion no erythema, no purulent discharge, not tender along tunnel route §Extremities : pitting edema 2+ § Neuro : good consciousness , follow to command, no facial palsy § No weakness , decrease pinprick sensation both lower legs , BBK plantar flexion
  • 23. Plain film KUB (repeat)
  • 24. Laboratory investigation Lab Result CBC Hb 9.4 g/dL, Hct 27.9 % MCV 84 fl. RDW 17 %, WBC 10,100, N 73.8%, L 12% M 14% E 0.1% B 0.2% Platelet 287,000 Blood chemistry BUN 99 Cr 12.9 mg/dL Na 138 K5.29 Cl 93.1 HCO3 16.3 mEq/L Ca 8.6 , P 3.4 mg/dL ABG pH 7.44, pCO2 24.4, pO2 113.2, HCO3 20
  • 25. Management § Consult surgery forTK catheter revision § Temporary acute hemodialysis
  • 26. Peritoneal Dialysis : Catheter Placement and Complication Management
  • 27. Requirement of catheter for dialysis adequacy §Peritoneal membrane w/o sclerosis/adhesions §Abdominal wall w/o leaks or hernias §Subcutaneous tract w/o infection §Skin exit site w/o infection §Catheter surface w/o persistent biofilm 5th edition Handbook of Dialysis
  • 28. Why Is Design or Surgical Technique Important? § Reduce risk for catheter-related complications Mechanical Complications Inadequate Hydraulic Function Omental Entrapment Leaks Infectious Complications Exit-Site Tunnel Peritonitis 5th edition Handbook of Dialysis
  • 29. Catheter Material § Catheters are made either of polyurethane or silicone § Either mupirocin or gentamicin - damage polyurethane § Manifestations of Damage: §Opacification of catheter §Leaks – leading to peritonitis §Rarely – rupture of catheter 5th edition Handbook of Dialysis
  • 30. Common used catheter set: Double cuff, swan neck, coiled Tenckhoff design. avoid cuff extrusions. 5-mm external diameter and internal diameters of 2.6 -3.5 mm. Decreases pain during PD and less likely to migrate. Nebel M, et al .Adv Perit Dial 7:208–213, 1991 Prevent infection (ESI,Tunnel infection, peritonitis)
  • 31. Internal diameters for PD catheters (outer diameter of 5 mm ) Flex-Neck Tenckhoff catheter (silicone) Internal diameter 3.5 mm Cruz Tenckhoff catheter (polyurethane) Internal diameter 3.1 mm standard Tenckhoff (silicone) Internal diameter 2.6 mm T-fluted catheter (Ash Advantage, silicone) Adapted from Crabtree J. Kidney Int Suppl 2006; 70: S27-37
  • 32. Proper position of peritoneal cuffs External Segment Tunneled Segment Intra-Peritoneal Segment Crabtree J. Kidney Int Suppl 2006; 70: S27-37
  • 33. Intraperitoneal portion 1. Straight Tenckhoff, 8-cm ,1-mm side holes 2. CurledTenckhoff, 16-cm, 1-mm side holes 3. Straight Tenckhoff/ perpendicular silicone discs (Toronto-Western) 4. T-fluted catheter (Ash Advantage), aT- shaped catheter with grooved limbs positioned against the parietal peritoneum 1 2 3 4 Crabtree J. Kidney Int Suppl 2006; 70: S27-37
  • 34. Superiority of intraperitoneal catheter design §No consistent data to support §2014 meta-analysis : straight segments compare with coiled §remain functional at 2 years (79 /55 %) §faster failure (1.4/2.1 yrs) (inadequate small-solute clearance §lower rate of late catheter tip migration (5VS 32 %) Hagen SM, et al . Kidney Int 2014; 85:920. Johnson et al,Am J Kidney Dis, 2006
  • 35.
  • 36. Subcutaneous portion §1-2 extraperitoneal Dacron (made from polyester) §Induce fibrous plug §fix catheter in position §prevent fluid leaks §prevent bacterial migration §Similar rates of ESI, peritonitis, migration, leakage, removal, and dysfunction
  • 37.
  • 38. Extraperitoneal portion Selection of swanneck or straight catheters determined by: -Belt line -Placement of exit site
  • 39. Insertion techniques § Percutaneous approach § Peritoneoscopic approach § Open surgical approach § Laparoscopic approach § Advanced laparoscopic (rectus sheath tunneling, selective prophylactic omentopexy and adhesiolysis) Choice of operator/technique depend on local expertise Joni H.Hansson et al,AJKD Update on Peritoneal Dialysis:Core Curriculum 2016
  • 40. Advanced laparoscopic : Rectus Sheath Tunneling
  • 41. Advanced laparoscopic : Omentopexy Guest S. Handbook of Peritoneal Dialysis, 2011
  • 42. Probability of Free of Mechanical Flow Obstruction At 24 Months Increased by Newer Techniques Crabtree JH et al .Am Surg . 2005 ; 71:135-143
  • 43. Proper position of Catheter §Intraperitoneal portion - between visceral and parietal peritoneum, near pouch of Douglas (cal de sac) § Hydraulic function of catheter AND § Minimize omental entrapment §Inner cuff should be inserted in rectus muscle to prevent leaks. §Outer cuff - subcutaneous tissue (create a dead space in between cuffs) approximate 2 cm §Subcutaneous tract and exit site should face downward and laterally to avoid exit site infection. Crabtree J. Kidney Int Suppl 2006; 70: S27-37
  • 44. Location of deep cuff Placingde ep cuff in abdominal musculature - promotes tissue ingrowth - minimizes pericatheter hernias, leaks - catheter extrusion, and exit site erosion
  • 45. Principle of exit site placement §Away from belt-lines, skin creases, and folds §Clearly visible to daily exit site care §About one inch from the superficial cuff
  • 46. Selection of various catheter Belt line below umbilicus à swan-neck catheter preferred if lateral point , a straight catheter is preferable Selected patients prefer uppper or presternal tips Crabtree J. Kidney Int Suppl 2006; 70: S27-37
  • 47. Presternal Exit-Site is Easily Visualized and Remote from Urostomy Guest S. Handbook of Peritoneal Dialysis, 2011
  • 48. Indication for presternal catheter § Morbid obesity § Floppy abdominal skin folds § Presence of stoma(colostomy, ileostomy, or urostomy) § Incontinence of urine or feces §Very young children who wear diapers § Patients with Hx of recurrent catheter infections Guest S. Handbook of Peritoneal Dialysis, 2011
  • 49. Postoperative catheter care §Covered with a nonocclusive dressing and should not be used for 10-14 days. §Catheter should be flushed at least 1-2 times /wk with saline or dialysate solution §Low-volume PD may be attempted within 24 hours in case of emergency Song JH, Kim GA, Lee SW, et al:. Perit Dial Int 2:194–199, 2000
  • 50. ISPD : Implantation protocol §Preoperative: § Check for hernias/ MRSA and nasal carriage of S. aureus; § Suitable catheter length § Marking exit site with the patient sitting or standing. • § Preparing bowel with laxatives; ensuring bladder emptying; administering prophylactic antibiotics § Post-procedure: flushing catheter and cap off using suitable dialysate § Covering exit site w/ dressing and, if possible, not disturbing for 5 – 10 days; § Immobilizing the catheter § Choice of antibiotic should be based upon local guidelines, with consideration given to efficacy, risks of selection of resistant organisms, and development of Clostridium difficile colitis ISPD CLINICAL PRACTICE GUIDELINES FOR PERITONEAL ACCESS , Peritoneal Dialysis International,Vol. 30, pp. 424–429, 2010
  • 51. Audit standards for catheter-related complications: §Bowel perforation: < 1% §Significant hemorrhage: < 1% §Exit-site infection in 2 weeks of insertion: < 5% §Peritonitis within 2 weeks of insertion: < 5% §Functional catheter problem requiring manipulation or replacement or leading to technique failure: < 20% §At least every 12 months, a combined meeting between surgeons (or other healthcare providers inserting PD catheters) and the nephrology team should be held to review PD catheter data ISPD CLINICAL PRACTICE GUIDELINES FOR PERITONEAL ACCESS , Peritoneal Dialysis International,Vol. 30, pp. 424–429, 2010
  • 52. Complication of chronic catheter §Peri-catheter leak §Infusion pain §Drain pain §Outflow failure §Cuff extrusion §Pleural effusion §EPS §Infection
  • 53. Early pericatheter leak §3 factors : § catheter implantation technique § timing of initiation § strength of abdominal wall tissues. §Confirmed by glucose dipstick indicating high glucose §Discontinue for 1–3 weeks usually spontaneous cessation §Leakage through exit site tunnel :: ↑ risk infection
  • 54. Late pericatheter leaks §Caused by pericannular hernia or occult tunnel infections, (with separation of the cuffs) §If abdominal wall is weak : track may dilate , develop true hernia. §Most late leaks and pericatheter hernias are best managed by catheter replacement.
  • 55. Pericatheter leakage §Treatment §Reduce physical activity §Reduce dialysate volumes §Conversion to cycler §Temporary conversion to HD §If conservative measures fails then surgical repair of deep cuff or catheter replacement
  • 56. Infusion pain § Usually resolved in several weeks in new patients § Persistent pain § Acidity (pH 5.2–5.5) of conventional lactate based dialysate § Use of bicarbonate/lactate- buffered dialysate (pH 7.0–7.4) § 1% or 2% lidocaine solution added to the dialysate (5 mL/L) §Other causes § hypertonic dialysate § aged dialysate § overdistended abdomen § extreme temperature § straight-tip cathters (jet effect). § catheter malposition with tip against abdominal wall
  • 57. Drain pain §Common in early days after initiation of dialysis. §Tip of catheter against sensitive parietal peritoneum § Constipation (bowel around catheter in pelvis) § More frequently in APD due to hydraulic suction § If persistent pain à avoid complete drainage of effluent
  • 58. Outflow failure §Definition: Incomplete recovery of instilled dialysate §Incidence: 5-20% §Etiologies §Constipation (anytime) §Catheter malposition (days) §Intraluminal catheter occlusion by thrombus §Extraluminal catheter occlusion by omentum or adhesions (weeks) §Kinking (soon after placement, positional) §Loss of dialysate from peritoneal cavity
  • 59. Diagnosis §History § Flow disturbance – inflow, outflow or both § When was the catheter placed § Constipation § Pain § Dyspnea § Fibrin in dialysate drain §Plain film § Severe constipation § Catheter malposition §Lost dialysate: pericatheter dialysate leakage; either internal or external
  • 60. Treatment §Constipation §More than half of the cases are cured with releif of constipation §Laxatives, stool softeners, suppositories or enema §Fibrin clot §Heparin 500-1000 units/L of dialysate for lysis §Urokinase – instilled in catheter for 1 hour and then removed §Recombinant tPA – used if obstruction is refractory
  • 61. Treatment §Malpositioned catheter §Fluoroscopy with stiff wire manipulation §Redirection either laproscopically or surgically §Replace catheter if not successful §Catheter kinking §Usually requires catheter replacement §Abdominal exploration may be necessary for catheter redirection, omentectomy or adhesiolysis or catheter replacement
  • 62.
  • 63. Catheter cuff extrusion §Catheter cuff erodes through the skin to the outer abdominal wall §Can be 2nd from ESI or superficial cuff placement §Incidence: 3.5 – 7%; no specific association with catheter type and method of placement §Treatment: depends on presence or absence of infection § No infection: extruding cuff removed by opening the subcutaneous tissue at exit site and trimming the cuff under sterile conditions § Infection present: remove the catheter
  • 64. Pleural effusion associated peritoneal dialysis §Possible etiologies: §Volume overload, CHF §Local pleural process §Peritoneal dialysate (pleuroperitoneal fistula) §Suspicion of peritoneal dialysate in a non-edematous pt with inadequate UF §Incidence: 1.6%, more common in females §ADPKD patients prone to have due to decreased abdominal capacity 5th edition Handbook of Dialysis
  • 65. Pleural effusion §Usually occurs early after starting PD §Unrelated to dialysate volumes §Hypotheses: §Congenital communication between pleura and peritoneum. Dissection of fluid through defects around major vessels and the esophagus §Combination of increased intra-abdominal pressure and negative intra-thoracic pressure may open small defects in the diaphragm 5th edition Handbook of Dialysis
  • 66. Pleural effusion §Clinical features §Can be asymptomatic §Dyspnea on exertion §Inadequate UF §More common on right side §Occurs early after PD initiation, 50% of cases within 1st month §Diagnosis: glucose level higher than serum (no cut point) § Nuclear scintigraphy is the most reliable test 5th edition Handbook of Dialysis
  • 67. Pleural effusion §Treatment: depends on acuity and severity §Thoracentesis §Drain peritoneal cavity and avoid overnight supine dwells §If recurrent and unresponsive: chemical pleurodesis using talc, tetracycline §Surgical correction if diaphragmatic defect is identified §Temporary conversion to HD 5th edition Handbook of Dialysis
  • 69. Hemoperitoneum § Benign causes §Menstruation/Ovulation §Trauma §Coagulopathy §Ruptured renal/ ovarian cyst §Serious causes §Ischemic bowel §Colon cancer §Pancreatitis §Encapsulating peritoneal sclerosis §Urologic malignancy §Treatment §IP heparin to avoid clotting of catheter §Flushes §Investigations depend on suspected cause 5th edition Handbook of Dialysis
  • 70. Encapsulating peritoneal sclerosis §Rare: Incidence: 0.5 – 2.8% § Stage 1- Pre-EPS stage: § Asymptomatic with mild ascites and no inflammation § Stage 2- Inflammatory stage: § nausea and diarrhea (partial encapsulation of bowel and intestinal swelling) § mild inflammation with fibrin exudation is present. § Stage 3- Encapsulation: § Symptoms of bowel obstruction due to formation of fibrous cocoon causing encapsulation. § Stage 4- Chronic stage of ileus: § Absolute bowel obstruction caused by thickening of encapsulating fibrous cocoon §Mortality: 30–63% §Both incidence and mortality increase with increased time on PD Nakamoto H Perit Dial Int. 2005 Apr; 25 Suppl 4():S30-8.
  • 71. Pathogenesis of EPS: “Two-hit” theory AugustineT, Nephron Clin Pract. 2009; 111(2):c149-54; discussion c154.
  • 72. EPS: Diagnosis §Markers of inflammation §Elevated CRP §Anemia, resistant to ESA’s §Hypoalbuminemia §Radiology: CT scan §Peritoneal thickening §Peritoneal calcification §Tethering and cocooning of bowel §Small or large bowel obstruction
  • 73. Nephrol DialTransplant (2006) 21 [Suppl 2]: ii38–ii41 Gross pathology of EPS
  • 74. CT Findings of EPS Cameron et al:American Roentgen Ray Society Annual Meeting, 2010
  • 75. CT Findings of EPS Cameron et al:American Roentgen Ray Society Annual Meeting, 2010
  • 76. EPS: Treatment §Corticosteroids: § Useful in inflammatory phase § Both pulse steroids or daily therapy can be used § Reported 38.5% remission rate with corticosteroids §Tamoxifen: case reports §Surgical treatment § Surgical lysis of intestinal adhesions and stripping of fibrous cocoon § Indications for surgery: § recurrent bowel obstruction § worsening nutritional status § failure medication Mario R. , et al Nature Reviews Nephrology 7, 528-538 (September 2011)
  • 77. Absolute contraindication for PD ที่มา :คู่มือบริหารกองทุนหลักประกันสุขภาพแห่งชาติ ปี งบประมาณ 2560
  • 81. Thank you for your attention